Mesa Laboratories Inc (MLAB)
Solvency ratios
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Debt-to-assets ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt-to-capital ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt-to-equity ratio | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Financial leverage ratio | — | 2.82 | 2.81 | 2.92 | 3.07 | 1.84 | 1.64 | 1.66 | 1.68 | 1.71 | 1.75 | 1.80 | 1.80 | 1.82 | 1.52 | 1.54 | 1.48 | 1.51 | 1.50 | 1.51 |
Mesa Laboratories Inc has shown consistent and impressive solvency ratios over the past few years.
The Debt-to-assets ratio has remained at 0.00 across all reported periods, indicating that the company has not relied heavily on debt to finance its assets. This suggests that Mesa Laboratories Inc has a strong financial position with a low risk of financial distress.
Similarly, the Debt-to-capital ratio and Debt-to-equity ratio have also remained at 0.00 consistently, indicating that the company is not taking on significant debt relative to its capital and equity. This reflects a healthy balance between debt and equity in the company's capital structure.
The Financial leverage ratio, which measures the extent to which the company is using debt financing, has shown some fluctuations over the years. While the ratio increased significantly in March 2024, it is important to note that this could be due to specific financing activities during that period.
Overall, Mesa Laboratories Inc's solvency ratios suggest a strong financial position and effective management of debt, capital, and equity, indicating a low risk of insolvency and a stable financial outlook for the company.
Coverage ratios
Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Interest coverage | 1.23 | -24.52 | -26.70 | -35.20 | -47.38 | 1.00 | 0.99 | 2.11 | 1.05 | 0.99 | 0.04 | 0.23 | 1.93 | 2.71 | 1.86 | 1.41 | 1.39 | 0.19 | 0.25 | 0.32 |
The interest coverage ratio for Mesa Laboratories Inc fluctuated significantly over the observed period. The company experienced a declining trend in interest coverage from June 30, 2020, to September 30, 2020, indicating a potential strain on its ability to cover interest expenses with its earnings. Subsequently, Mesa Laboratories Inc managed to improve its interest coverage ratio, reaching its highest point on December 31, 2024.
However, it is noteworthy that the interest coverage ratio turned negative in the first two quarters of 2024, suggesting a potential concern regarding the company's ability to meet interest obligations solely based on its operating income during that period. The substantial negative ratio during these quarters indicates that the company's earnings were not sufficient to cover its interest expenses.
Overall, Mesa Laboratories Inc's interest coverage ratio improved over the period, with some fluctuations, but the negative ratios in the first half of 2024 raise questions about the company's financial stability and ability to service its debt through operational earnings. Monitoring this ratio closely in the future will be crucial for assessing the company's financial health and ability to meet its interest obligations.